German Engineering

Used by patients in over 100 countries

Safe and reliable products

About BIOTRONIK

BIOTRONIK is a medical technology company that develops trusted and innovative cardiovascular and endovascular solutions. Driven by purpose and integrity, BIOTRONIK has partnered with hospitals and health systems for more than 50 years, helping to deliver care that saves and improves the lives of millions of patients with heart and blood vessel diseases. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries. BIOTRONIK has US offices in New York City and Lake Oswego, Oregon.

At BIOTRONIK, we are committed to helping people with heart and blood vessel diseases live healthy, fulfilling lives. This immense responsibility motivates thousands of employees worldwide to develop new cardiovascular and endovascular medical technologies that physicians trust to save and improve patient lives. Our unique, safe and reliable products, including pacemakers, stents, implantable defibrillators and remote monitoring services.

What Is a CRT-D?   

A Biventricular ICD is also known as a CRT-D device. CRT-D is an implantable cardiac resynchronization therapy (CRT) defibrillator for patients with   heart failure. The device monitors the heart's rhythm, detects irregularities and corrects them with electrical impulses. Like an implantable defibrillator (ICD), a CRT-D is designed to stop life-threatening ventricular tachycardia and fibrillation with relatively weak and painless stimulation therapy or electrical shocks. CRT-Ds differ from ICDs in that they help your heart’s lower chambers – the ventricles – work in tandem. To do this, CRT-Ds have three leads – wires that deliver energy to the heart – rather than one or two, as in an ICD. A CRT-P is a cardiac resynchronization therapy pacemaker that does not have the defibrillation capabilities of a CRT-D. CRT-Ds enhance diseased hearts’ effectiveness and increase blood flow. They improve heart failure symptoms like fatigue, shortness of breath and exercise intolerance. Cardiac resynchronization therapy significantly lowers the risk of life-threatening cardiac events. Many patients’ quality of life improves significantly with a CRT-D. Surgery is necessary to implant a CRT-D.

Rivacor CRT-D

Rivacor devices incorporate more diagnostic and therapeutic capabilities into smaller devices. The Ultraslim BIOshape eases implantation, features a thinner form factor and a more rounded, elliptical design for reduced skin pressure. They are the smallest and slimmest CRT-Ds approved for 3T full-body MRI scans. Rivacor CRT-Ds have an extended battery life of nearly 11 years, supported by extended warranties, to deliver the best patient care.

K E Y    F E A T U R E S

MR CONDITIONAL CRT-D DEVICE